Chorismate mutase (CM) catalyzes the rearrangement of chorismate to prephenate in the biosynthetic pathway that forms phenylalanine and tyrosine in bacteria, fungi, plants, and apicomplexan parasites. Since this enzyme is absent from mammals, it represents a promising target for the development of new antimycobacterial drugs, which are needed to combat Mycobacterium tuberculosis, the causative agent of tuberculosis. Until recently, two putative open reading frames (ORFs), Rv0948c and Rv1885c, showing low sequence similarity to CMs have been described as "conserved hypothetical proteins" in the M. tuberculosis genome. However, we and others demonstrated that these ORFs are in fact monofunctional CMs of the AroQ structural class and that they are differentially localized in the mycobacterial cell. Since homologues to the M. tuberculosis enzymes are also present in Mycobacterium smegmatis, we cloned the coding sequences corresponding to ORFs MSMEG5513 and MSMEG2114 from the latter. The CM activities of both ORFs was determined, as well as their translational start sites. In addition, we analyzed the promoter activities of three M. tuberculosis loci related to phenylalanine and tyrosine biosynthesis under a variety of conditions using M. smegmatis as a surrogate host. Our results indicate that the aroQ (Rv0948c), *aroQ (Rv1885c), and fbpB (Rv1886c) genes from M. tuberculosis are constitutively expressed or subjected to minor regulation by aromatic amino acids levels, especially tryptophan.
Tuberculosis (TB), a serious infectious disease caused byMycobacterium tuberculosis, still remains a public health problem in the world. It has been estimated that one-third of the world's population is latently infected with M. tuberculosis and that almost 9 million new cases and 2 million deaths occur each year (19). The low efficacy of the currently available TB vaccine (Mycobacterium bovis BCG), the emergence of multidrug-resistant strains of M. tuberculosis, and the global spread of human immunodeficiency virus (which increases the risk of TB development) are among the factors underlying the resurgence of TB (24). New drugs and second-generation vaccines are urgently required to control TB, but the complex biology of M. tuberculosis has hindered the development of novel therapeutic tools.M. tuberculosis is a sophisticated intracellular pathogen that can persist for months or years within the human host, and different mechanisms related to its entry, survival, and replication in macrophages are involved in the infection process (51, 56). The bacilli are notably able to interfere with normal macrophage functions, such as antigen presentation and phagosome maturation, residing in a specialized, nonacidified compartment (44). Of particular interest is the fact that important nutrients are restricted or unavailable inside macrophages, so that M. tuberculosis cells are probably subjected to long-term starvation during the early and latent stages of infection (6,36,50). Since many anabolic and catabolic pathways should be specifical...